COMMENTARY: Amlodipine plus perindopril was better than atenolol plus bendroflumethiazide for reducing complications in hypertension

Zarnke, Kelly B.
March 2006
ACP Journal Club;Mar/Apr2006, Vol. 144 Issue 2, p32
Academic Journal
The article focuses on a study which revealed that amlodipine plus perindopril was better than atenolol plus bendroflumethiazide for reducing complications in hypertension. The clinical trial compared a calcium blocker with a beta-blocker in high-risk patients with hypertension. Many hypertensive patients with various forms of heart disease will benefit from use of beta-blockers. Thiazide diuretics can act as highly appropriate first-line therapy for many patients with hypertension.


Related Articles

  • Beta-Blockers for the Treatment of Essential Hypertension: What are the Arguments Against Their Use as First Line Therapy? Burnier, Michel; Bullani, Roberto; Vogt, Bruno // Current Hypertension Reviews;2007, Vol. 3 Issue 1, p15 

    Beta-blockers are recommended as first line therapy in the treatment of essential hypertension since several decades and this recommendation has been endorsed by most if not all national and international guideline committees. Some concerns about their efficacy in elderly hypertensive patients...

  • Assessment of Heart Rate Variability after Calcium Antagonist and β-Blocker Therapy in Patients with Essential Hypertension. Rabbia, F.; Martini, G.; Sibona, M.P.; Grosso, T.; Simondi, F.; Chiandussi, L.; Veglio, F. // Clinical Drug Investigation;1999, Vol. 17 Issue 2, p111 

    Objective: Antihypertensive agents of different classes may have profound effects on heart rate variability (HRV). HRV changes in patients with essential hypertension were evaluated after pharmacological treatment by time domain (TD) analysis on 24-hour electrocardiographic (ECG) recordings....

  • Application of Hydrotropic Solubilisation in Simultaneous Estimation of Atenolol and Amlodipine Besylate. Gurumurthy, V.; Deveswaran, R.; Bharath, S.; Basavaraj, B.V.; Madhavan, V. // Asian Journal of Research in Chemistry;Jan2012, Vol. 5 Issue 1, p57 

    The present investigation was aimed to estimate atenolol and amlodipine besylate simultaneously from bulk drug and tablets using hydrotropic solubilization technique employing 4M urea as hydrotropic solvent. Atenolol showed maximum absorbance at 224.5nm, whereas amlodipine besylate showed...

  • Tenif.  // Royal Society of Medicine: Medicines;2002, p526 

    The article presents information on Tenif, a proprietary, prescription-only compound preparation of the beta-blocker atenolol and the calcium-channel blocker nifedipine. It can be used as an antihypertensive for raised blood pressure and in anti-angina treatment. It is available as capsules.

  • Current perspectives on treatment of hypertensive patients with chronic obstructive pulmonary disease. Chandy, Dipak; Aronow, Wilbert S.; Banach, Maciej // Integrated Blood Pressure Control;2013, Vol. 6, p101 

    Systemic hypertension and chronic obstructive pulmonary disease (COPD) frequently coexist in the same patient, especially in the elderly. Today, a wide variety of antihypertensive drugs with different mechanisms of action are available to the prescribing physician. In addition, combination drugs...

  • Nebivolol/Hydrochlorothiazide. Malacco, Ettore // High Blood Pressure & Cardiovascular Prevention;May2008, Vol. 15 Issue 2, p75 

    Hypertension is a major independent risk factor for cardiovascular (CV) morbidity and mortality and is combined with additional CV risk factors, such as diabetes mellitus, dyslipidaemia, heart disease, metabolic syndrome, smoking and obesity in many hypertensive individuals. The prevention of CV...

  • CUTANEOUS REACTIONS DUE TO ANTIHYPERTENSIVE DRUGS. Upadhayai, J. B.; Nangia, Anup Kumar; Mukhija, R. D.; Misra, Mukum; Mohan, Lalit; Singh, K. K. // Indian Journal of Dermatology;2006, Vol. 51 Issue 3, p189 

    Out of a total of 1147 patients on antihypertensive drugs, 23 (2.04%) developed adverse cutaneous drug reactions (ACDR). The commonest antihypertensive drug group causing ACDR was beta-blockers of which atenolol was the commonest culprit. The second most common group was calcium channel blockers...

  • Safety fears stop beta-blocker trial. Baines, Emma // GP: General Practitioner;12/17/2004, p2 

    This article informs that a large drug trial has been stopped early after it was found that patients treated with beta-blockers and thiazides were more likely to have a cardiovascular event than those in the group who were given newer antihypertensive treatment. This could mean that...

  • Angioplasty/stenting takes another hit. HOLLINGSWORTH, CATHERINE // Cardiovascular Devices & Drugs;Sep2008, Vol. 14 Issue 9, p13 

    The article discusses research on the cost effectiveness of angioplasty and stenting. It references a study conducted by William Weintraub of Christiana Care Health System and colleagues, published in an issue of the "New England Journal of Medicine." The researchers examined 2,287 patients with...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics